Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
GDRX

GDRX - GoodRx Holdings Inc Stock Price, Fair Value and News

8.80USD-0.05 (-0.56%)Market Closed

Market Summary

GDRX
USD8.80-0.05
Market Closed
-0.56%

GDRX Alerts

  • Big jump in Earnings (Y/Y)
  • Losses in recent quarter

GDRX Stock Price

View Fullscreen

GDRX RSI Chart

GDRX Valuation

Market Cap

3.4B

Price/Earnings (Trailing)

-521.09

Price/Sales (Trailing)

4.49

EV/EBITDA

32.82

Price/Free Cashflow

23.3

GDRX Price/Sales (Trailing)

GDRX Profitability

EBT Margin

-7.70%

Return on Equity

-1.04%

Return on Assets

-0.45%

Free Cashflow Yield

4.29%

GDRX Fundamentals

GDRX Revenue

Revenue (TTM)

764.2M

Rev. Growth (Yr)

7.55%

Rev. Growth (Qtr)

0.63%

GDRX Earnings

Earnings (TTM)

-6.6M

Earnings Growth (Yr)

69.33%

Earnings Growth (Qtr)

96.1%

Breaking Down GDRX Revenue

Last 7 days

4.7%

Last 30 days

32.1%

Last 90 days

30.7%

Trailing 12 Months

53.9%

How does GDRX drawdown profile look like?

GDRX Financial Health

Current Ratio

6.29

Debt/Equity

1.02

Debt/Cashflow

0.23

GDRX Investor Care

Buy Backs (1Y)

5.43%

Diluted EPS (TTM)

-0.01

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024764.2M000
2023747.2M745.1M737.7M750.3M
2022788.3M803.5M795.7M766.6M
2021577.7M631.1M685.7M745.4M
2020428.8M469.5M510.1M550.7M
201900318.9M388.2M
2018000249.5M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of GoodRx Holdings Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jun 10, 2024
hirsch douglas joseph
gifted
-
-
2,632,720
chief mission officer
Jun 10, 2024
bezdek trevor
gifted
-
-
2,632,720
chairman
Jun 10, 2024
bezdek trevor
gifted
-
-
-2,632,720
chairman
Jun 10, 2024
hirsch douglas joseph
gifted
-
-
-2,632,720
chief mission officer
Jun 08, 2024
wagner scott
sold (taxes)
-305,885
8.55
-35,776
see remarks
Jun 08, 2024
nabiey romin
sold (taxes)
-37,936
8.55
-4,437
chief accounting officer

1–10 of 50

Which funds bought or sold GDRX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 20, 2024
Highlander Capital Management, LLC
sold off
-100
-5,025
-
-%
May 16, 2024
JANE STREET GROUP, LLC
added
27.09
299,425
1,162,760
-%
May 16, 2024
INNEALTA CAPITAL, LLC
unchanged
-
5,422
96,241
0.04%
May 16, 2024
Beacon Capital Management, LLC
new
-
28,400
28,400
0.01%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
added
5.1
51,439
503,475
-%
May 15, 2024
SQN Investors LP
sold off
-100
-8,561,900
-
-%
May 15, 2024
Tower Research Capital LLC (TRC)
added
3,943
223,742
229,089
0.01%
May 15, 2024
Rip Road Capital Partners LP
added
17.08
2,843,120
14,657,100
12.98%
May 15, 2024
GOLDMAN SACHS GROUP INC
reduced
-24.05
-72,154
297,632
-%
May 15, 2024
Walleye Capital LLC
sold off
-100
-80,923
-
-%

1–10 of 43

Are Funds Buying or Selling GDRX?

Are funds buying GDRX calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own GDRX
No. of Funds

Unveiling GoodRx Holdings Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Jun 11, 2024
goodrx holdings, inc.
5.6%
5,265,442
SC 13D/A
Jun 11, 2024
goodrx holdings, inc.
5.6%
5,265,442
SC 13D/A
May 02, 2024
millennium management llc
5.1%
4,833,570
SC 13G
Mar 08, 2024
francisco partners iv, l.p.
28.6%
46,680,496
SC 13D/A
Mar 08, 2024
spectrum equity vii, l.p.
24.2%
29,825,306
SC 13D/A
Feb 14, 2024
ameriprise financial inc
7.58%
7,001,503
SC 13G
Feb 13, 2024
vanguard group inc
9.07%
8,380,990
SC 13G/A
Feb 12, 2024
rubric capital management lp
6.36%
5,872,806
SC 13G
Jan 25, 2024
millennium management llc
0.7%
602,934
SC 13G/A
Nov 21, 2023
spectrum equity vii, l.p.
30.9%
36,048,589
SC 13D/A

Recent SEC filings of GoodRx Holdings Inc

View All Filings
Date Filed Form Type Document
Jun 11, 2024
4
Insider Trading
Jun 11, 2024
4
Insider Trading
Jun 11, 2024
SC 13D/A
13D - Major Acquisition
Jun 11, 2024
SC 13D/A
13D - Major Acquisition
Jun 10, 2024
4
Insider Trading
Jun 10, 2024
4
Insider Trading
Jun 10, 2024
4
Insider Trading
Jun 10, 2024
4
Insider Trading
Jun 10, 2024
4
Insider Trading
Jun 10, 2024
4
Insider Trading

Peers (Alternatives to GoodRx Holdings Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
457.7B
379.5B
-3.65% 0.77%
29.8
1.21
12.96% -25.81%
94.9B
206.0B
-3.75% 23.43%
24.62
0.46
12.55% -43.95%
89.3B
66.7B
7.45% 22.04%
16.32
1.34
9.59% -4.59%
76.6B
360.9B
6.23% -16.98%
10.46
0.21
9.07% 78.83%
36.8B
155.5B
-12.24% -2.53%
13.46
0.24
6.34% 84.42%
12.6B
14.7B
4.84% 32.82%
15.48
0.86
7.99% 19.23%
12.5B
12.3B
4.47% 45.25%
15.28
1.01
5.77% 58.74%
MID-CAP
8.1B
2.3B
-4.83% -0.18%
28.7
3.55
5.96% 18.29%
6.2B
3.0B
-5.43% -3.06%
-544.54
2.06
10.92% -104.06%
2.2B
1.5B
0.05% 19.70%
34.9
1.5
19.34% 40.15%
2.0B
3.5B
-9.25% -51.02%
14.21
0.59
-27.67% -62.40%
SMALL-CAP
1.9B
1.1B
7.13% 25.50%
28.96
1.75
11.45% 30.74%
1.3B
3.0B
-3.72% 59.10%
-7.38
0.42
4.98% 4.88%
53.4M
-
13.00% -23.39%
-3.54
-
- -1.05%
20.7M
21.6M
-6.30% 25.29%
40.75
0.96
9.04% -57.88%

GoodRx Holdings Inc News

Latest updates
Marketscreener.com34 hours ago

GoodRx Holdings Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32018Q4
Revenue0.6%198197180190184184187192203213195177160154140123133118102-
Costs and Expenses-11.4%19021521817117318220319618420218817716545320282.0090.00-64.00-
  S&GA Expenses-4.0%90.0094.0092.0077.0079.0084.0086.0094.0093.0010696.0088.0080.0075.0065.0052.0063.00-45.00-
  R&D Expenses-3.2%31.0032.0040.0031.0033.0037.0036.0035.0035.0035.0035.0030.0026.0024.0016.0012.0010.00-8.00-
EBITDA Margin-2.5%0.14*0.15*0.13*0.13*0.09*0.09*0.08*0.10*0.10*0.06*-0.39*-0.54*-0.53*-0.47*0.29*0.31*0.34*0.38*0.26*0.34*
Interest Expenses-1.2%15.0015.0015.0014.0013.0012.009.007.006.006.006.006.006.006.006.007.009.00-13.00-
Income Taxes5.5%1.001.00-8.11-46.727.00-2.7719.00-8.742.0046.0019.00-37.30-12.55-7.36-17.898.008.00-6.00-
Earnings Before Taxes101.2%0.00-24.63-46.6012.004.00-4.74-22.27-10.1614.006.001.00-6.24-10.89-305-67.9335.0035.00-25.00-
EBT Margin-4.0%-0.08*-0.07*-0.05*-0.02*-0.04*-0.03*-0.02*0.01*0.02*-0.01*-0.47*-0.62*-0.60*-0.55*0.16*0.18*0.19*0.21*0.16*0.21*
Net Income96.1%-1.01-25.87-38.4959.00-3.29-1.97-41.73-1.4112.00-39.91-18.0731.002.00-298-50.0327.0027.0015.0020.00-
Net Income Margin27.1%-0.01*-0.01*0.02*0.02*-0.06*-0.04*-0.09*-0.06*-0.02*-0.03*-0.41*-0.50*-0.55*-0.53*0.04*0.19*0.19*0.17*0.14*0.18*
Free Cashflow172.8%42.0015.0060.0030.0032.0032.0033.0050.0028.0049.0048.0035.0043.0010.0019.0037.0045.00---
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32019Q4
Assets-8.5%1,4541,5891,7081,6921,6121,6051,5671,5921,5381,6081,6141,5871,5111,4701,547387
  Current Assets-16.0%7338739699199079208788949951,0891,0521,0761,1231,0861,18187.00
    Cash Equivalents-20.7%5336727957627617577297318459419128959909691,07526.00
  Net PPE-3.7%15.0016.0017.0018.0019.0020.0022.0023.0023.0022.0022.0022.0023.0023.0017.002.00
  Goodwill0%41141141241241241241541581.00330330320261261261236
Liabilities-0.5%823827827797784790779774752776768763762759790737
  Current Liabilities-4.9%11712311883.0069.0076.0085.0080.0059.0081.0073.0065.0063.0060.0060.0033.00
  Long Term Debt-0.2%647648649650651652653654655656657658659660689664
    LT Debt, Current-20.0%7.009.007.007.007.007.007.007.007.007.007.007.007.007.007.007.00
    LT Debt, Non Current-0.2%647648649650651652653654655656657658659660689664
Shareholder's Equity-17.2%631762881895827815788818787832846824749711756-
  Retained Earnings-0.1%-1,458-1,457-1,431-1,393-1,451-1,448-1,446-1,404-1,403-1,415-1,375-1,357-1,388-1,390-1,092-1,096
  Additional Paid-In Capital-5.9%2,0892,2192,3132,2882,2792,2632,2352,2232,1902,2472,2222,1822,1382,1021,8499.00
Shares Outstanding-4.9%390410413412412413413412415410411407406275234227
Float----424---472---2,300----
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32018Q4
Cashflow From Operations168.4%42,58615,86860,27029,86632,28831,87933,73251,04930,12049,81048,55834,92645,48514,85032,66638,23345,592---
  Share Based Compensation-12.8%25,09628,77832,64617,89725,49956,3503,2003,60030,14916,8003,0003,90046,526232,1005001,7002,210-300-
Cashflow From Investing-60.2%-20,615-12,872-13,647-14,959-14,2881,286-13,775-163,608-34,401-9,259-27,058-132,721-9,695-9,810-73,488-4,912-3,407---
Cashflow From Financing-28.2%-160,972-125,605-13,706-13,994-14,090-4,786-21,711-2,328-91,401-11,465-4,180-865-14,018-111,373992,121-2,53327,602---
  Buy Backs96.9%153,22677,8257,7128,9209,517-17,956-83,765-----------
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

GDRX Income Statement

2024-03-31
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue$ 197,880$ 183,986
Costs and operating expenses:  
Cost of revenue, exclusive of depreciation and amortization presented separately below12,46816,695
Product development and technology31,01732,908
Sales and marketing89,96478,522
General and administrative41,10829,619
Depreciation and amortization15,94214,939
Total costs and operating expenses190,499172,683
Operating income7,38111,303
Other expense, net:  
Other expense0(1,808)
Interest income7,5557,234
Interest expense(14,643)(13,133)
Total other expense, net(7,088)(7,707)
Income before income taxes2933,596
Income tax expense(1,302)(6,886)
Net loss$ (1,009)$ (3,290)
Loss per share:  
Basic (in usd per share)$ (0.00)$ (0.01)
Diluted (in usd per share)$ (0.00)$ (0.01)
Weighted average shares used in computing loss per share:  
Basic (in shares)390,048412,429
Diluted (in shares)390,048412,429
Cost of revenue  
Stock-based compensation included in costs and operating expenses:  
Total stock-based compensation$ 76$ 161
Product development and technology  
Stock-based compensation included in costs and operating expenses:  
Total stock-based compensation5,8488,589
Sales and marketing  
Stock-based compensation included in costs and operating expenses:  
Total stock-based compensation8,1274,412
General and administrative  
Stock-based compensation included in costs and operating expenses:  
Total stock-based compensation$ 11,045$ 12,337

GDRX Balance Sheet

2024-03-31
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets  
Cash and cash equivalents$ 533,295$ 672,296
Accounts receivable, net144,769143,608
Prepaid expenses and other current assets54,73556,886
Total current assets732,799872,790
Property and equipment, net15,34115,932
Goodwill410,769410,769
Intangible assets, net58,12260,898
Capitalized software, net103,98095,439
Operating lease right-of-use assets, net30,92829,929
Deferred tax assets, net65,26865,268
Other assets36,75637,775
Total assets1,453,9631,588,800
Current liabilities  
Accounts payable33,51836,266
Accrued expenses and other current liabilities70,84371,329
Current portion of debt7,0298,787
Operating lease liabilities, current5,1316,177
Total current liabilities116,521122,559
Debt, net646,678647,703
Operating lease liabilities, net of current portion51,33948,403
Other liabilities8,3568,177
Total liabilities822,894826,842
Commitments and contingencies
Stockholders' equity  
Preferred stock, $0.0001 par value; 50,000 shares authorized and zero shares issued and outstanding at March 31, 2024 and December 31, 202300
Common stock, $0.0001 par value; Class A: 2,000,000 shares authorized, 94,074 and 92,355 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively; and Class B: 1,000,000 shares authorized, 280,869 and $301,732 shares issued and outstanding at March 31, 2024 and December 31, 20233840
Additional paid-in capital2,089,4432,219,321
Accumulated deficit(1,458,412)(1,457,403)
Total stockholders' equity631,069761,958
Total liabilities and stockholders' equity$ 1,453,963$ 1,588,800
GDRX
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is headquartered in Santa Monica, California.
 WEBSITEgoodrx.com
 INDUSTRYHealthcare Plans
 EMPLOYEES952

GoodRx Holdings Inc Frequently Asked Questions


What is the ticker symbol for GoodRx Holdings Inc? What does GDRX stand for in stocks?

GDRX is the stock ticker symbol of GoodRx Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of GoodRx Holdings Inc (GDRX)?

As of Wed Jun 12 2024, market cap of GoodRx Holdings Inc is 3.45 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of GDRX stock?

You can check GDRX's fair value in chart for subscribers.

What is the fair value of GDRX stock?

You can check GDRX's fair value in chart for subscribers. The fair value of GoodRx Holdings Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of GoodRx Holdings Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for GDRX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is GoodRx Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether GDRX is over valued or under valued. Whether GoodRx Holdings Inc is cheap or expensive depends on the assumptions which impact GoodRx Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for GDRX.

What is GoodRx Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Jun 12 2024, GDRX's PE ratio (Price to Earnings) is -524.05 and Price to Sales (PS) ratio is 4.52. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. GDRX PE ratio will change depending on the future growth rate expectations of investors.